🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bobby B. Shih

Columbia University Irving Medical Center

ORCID: 0000-0003-0193-8263

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma”.

Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma

Cell Reports(2022)10.1016/j.celrep.2022.110695

N/A

0.869DataRank · unranked

26 citations

Ioan Filip, Robert Alberó, Juan Ángel Patiño-Galindo, S. Aidan Quinn, Wen-Hsuan W. Lin +16 more

Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology(2021)10.1016/j.jid.2021.04.023

N/A

0DataRank · unranked

26 citations

Christina C. Patrone, S. Aidan Quinn, Yuhan Gu, Marta Sánchez-Martín, Adam L. Mackey +8 more

RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor

Journal of the American Chemical Society(2024)10.1021/jacs.4c01720

N/A

0DataRank · unranked

13 citations

Cindy Ma, Bobby B. Shih, Hannah I. Miller, Rafael Yuste, Teresa Palomero +2 more

Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology(2024)10.1016/j.jid.2023.12.010

N/A

0DataRank · unranked

8 citations

Cindy Ma, José R. Cortés, Clara Reglero, Hannah I. Miller, S. Aidan Quinn +7 more